Details for 2017727373
Up to date per 08.05.2026
Actions
Details for 2017727373
Granted/Registered
European Patent
27.02.2019 A
17.04.2024 B1
18.04.2016
US
201662324024 P
01.09.2016
US
201662382522 P
02.12.2016
US
201662429428 P
A61K 38/46 20060101AFI20181029BHEP
Owner
Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
COWAN, Chad, Albert610 Main Street North Building 7th Floor Cambridge, MA 02139US
LUNDBERG, Ante, Sven610 Main Street North Building 7th Floor Cambridge, MA 02139US
CHAKRABORTY, Tirtha610 Main Street North Building 7th Floor Cambridge, MA 02139US
LIN, Michelle, I-ching610 Main Street North Building 7th Floor Cambridge, MA 02139US
MISHRA, Bibhu, Prasad610 Main Street North Building 7th Floor Cambridge, MA 02139US
PAIK, Elizabeth, Jae-eun610 Main Street North Building 7th Floor Cambridge, MA 02139US
KERNYTSKY, Andrew610 Main Street North Building 7th Floor Cambridge, MA 02139US
BORLAND, Todd, Douglass610 Main Street North Building 7th Floor Cambridge, MA 02139US
Information about Fees